Red Sox’ Chris Sale to Undergo Tommy John Surgery

Red Sox ace left-hander Chris Sale will undergo Tommy John surgery on his left elbow, the team officially announced Thursday.

This news comes one day after it was reported by The Boston Globe’s Alex Speier that Sale had recently begun another throwing program in Fort Myers nearly three weeks after throwing to live hitters for the first time since last year at the beginning of the month.

The day after throwing that live bullpen session, Sale began to feel discomfort in the same left elbow he had issues with in 2019, and the results of his MRI revealed a flexor tendon strain. Those results were sent over to esteemed sports medicine specialists Dr. James Andrews and Dr. Neil ElAttrache, but neither doctor recommended surgery at the time and instead prescribed Sale with rest since his ulnar collateral ligament (UCL) was “unchanged”, per interim manager Ron Roenicke.

While speaking with reporters in a conference call on Thursday, Red Sox chief baseball officer Chaim Bloom explained that Sale began throwing again last Friday, then threw a light session on Sunday, but had to be shut down while throwing outside on Tuesday due to the pain he felt in that elbow. That’s how the decision for the left-hander to go under the knife was reached.

According to Bloom, the date for Sale’s surgery has not yet been set, but he does “expect it to be soon, in the fairly near future.”

The recovery time for a pitcher undergoing Tommy John surgery is typically anywhere between 12 to 15 months, so depending on when Sale does have it, he will miss the entirety of the 2020 season, whenever that starts, as well as some time in 2021.

Sale, who turns 31 later this month, is set to earn $30 million this season in the first year of the five-year, $145 million contract extension he signed with Boston last March.

The Florida native missed the final six weeks of the 2019 campaign due to inflammation in his left elbow and dealt with a bout of pneumonia right around the time camp broke this year.

Without Sale in their plans, the Red Sox’ starting rotation will be composed of Eduardo Rodriguez, Nathan Eovaldi, and Martin Perez. Outside of those three, Ryan Weber had looked solid in his handful of spring starts, while Roenicke also mentioned Brian Johnson and an opener as potential rotation options on Thursday.

“”It’s never just about one season. We’re always going to make sure we’ll bolster our long-term outlook as well,” Bloom said in regard to this year’s Red Sox. “Losing Chris for 2020 isn’t going to make our task any easier.”

Advertisement

Red Sox’ Chris Sale Has Flexor Strain

Red Sox ace left-hander Chris Sale has a flexor tendon strain in his left elbow, according to interim manager Ron Roenicke.

This news comes one day after Sale received a third opinion from Dr. Neil ElAttrache, after already getting a second opinion from Dr. James Andrews, in regard to the MRI of his sore left elbow.

Since his Ulnar Collateral Ligament (UCL) was “unchanged”, Sale has at least avoided surgery for the time being, as it was not recommended by either doctor. Instead, he has been prescribed rest and will not throw again for another week or so.

After that period of rest, Sale will begin throwing again and will need to be pain free while doing so. If he does still feel the same pain in his left elbow he experienced last year, then it might be time to assume the worst-case scenario.

“It sucks,” Sale said Thursday. “I know what I’m worth to this team and I don’t want to do anything stupid.”

The soon-to-be 31-year-old was already set to miss about the first two weeks of the 2020 season due to an earlier bout with pneumonia, but this setback will surely push his return date back even further depending on how things go at the end of next week.

This all comes as Sale enters the first year of the five-year, $145 million extension he signed with Boston last March. He will earn $25.6 million in 2020.

 

Red Sox Waiting for Another Opinion on Chris Sale’s Sore Left Elbow

One day after it was revealed that left-hander Chris Sale was dealing with soreness in his left elbow and an MRI had been sent to elbow specialist Dr. James Andrews, the Red Sox are now seeking a third opinion from another specialist in Dr. Neil ElAttrache, according to interim manager Ron Roenicke.

Sale reported the elbow soreness to the team’s medical staff on Monday, one day after throwing 15 pitches while facing live hitters for the first time since last August.

At that time, he was diagnosed with inflammation in his left elbow and received a platelet-rich plasma injection from Dr. Andrews that same month before eventually being shut down for the remainder of the 2019 campaign.

The Florida native was cleared to begin throwing again in late November, though, and outside of a bout with pneumonia, he seemed completely healthy otherwise headed into the spring. But now, it appears that his 2020 season could be in jeopardy.

Roenicke did say to not assume the worst-case scenario with Sale until the Red Sox have gathered all the necessary information, and he emphasized how they “want to get this right.”

Still, as The Boston Globe’s Pete Abraham notes, “teams usually don’t get a third opinion to confirm good news. Getting opinions from Andrews and ElAttrache certainly suggests there’s a significant injury.”

According to Roenicke, the Red Sox should have word from Dr. ElAttrache within “the next day or so.

Until then, stay tuned for more updates.

Red Sox’ Chris Sale Dealing With Left Elbow Soreness

Red Sox ace left-hander Chris Sale is dealing with soreness in his left elbow, according to interim manager Ron Roenicke.

Per Roenicke, Sale first experienced the soreness on Monday, one day after facing live hitters for the first time since last August. He has since been sent for an MRI and the Red Sox are awaiting the results from Dr. James Andrews.

Sale, who turns 31 later this month, was already expected to begin the 2020 season on the injured list due to an earlier bout with pneumonia that would have delayed his spring preparations, but this recent news adds another layer of concern.

In that live batting practice session on a Fenway South backfield on Sunday, Sale threw 15 pitches while utilizing his entire pitch mix, and did not feel any pain in his arm upon the session’s completion.

Heading into what is now the first year of the five-year, $145 million extension he signed with Boston last March, Sale’s left elbow has received plenty of attention over the past 12 months.

The Florida native was shut down by the Sox due to inflammation in that same elbow last August, and he received a platelet-rich plasma (PRP) injection from Dr. Andrews later that same month.

He was eventually cleared to resume throwing right around Thanksgiving, though, and up until Tuesday morning, any developments related to his left arm seemed to be positive and encouraging.

With the results of the MRI yet to be revealed, it’s unclear on where things will go from here. Worst-case scenario is most likely season-ending surgery, but we really don’t know anything yet.

What we do know is that a Red Sox starting rotation that already faced plenty of skepticism will face even more if Sale is indeed sidelined for an even longer period of time than initially anticipated.

 

Red Sox’ Chris Sale Has Pneumonia

Red Sox ace left-hander Chris Sale has pneumonia, according to interim manager Ron Roenicke.

“He’s got the flu as you guys know,” Roenicke told reporters after the team’s first workout at JetBlue Park on Wednesday. “But it’s gone into a mild case of pneumonia. He is actually feeling really good. He’s had this for about a week and a half.”

Sale, who was absent from Wednesday’s workout, will be reevaluated on Friday, per Roenicke.

“it sounds probably worse than what it is,” the interim skipper added. “But he said last night he had a great night sleep. So he was really happy about it.”

Obviously, this is not the news you want to hear just as spring training begins. But, it does seem as if Sale will be good to go come the end of the week, which is promising.

The soon-to-be 31-year-old hurler is coming off his worst season in the majors last year after posting a 4.40 ERA over 25 starts and just 147 1/3 innings of work. He did not make a start after August 13th due to left elbow inflammation.

That inflammation was treated with a PRP injection from Dr. James Andrews that same month, and Sale was cleared to throw again in December. According to Sox general manager Brian O’Halloran, the lefty’s arm is “fully healthy.”

“We expected Chris to be ready to go,” O’Halloran said Tuesday. “He’s ill. He’s sick, so that’s going to slow him down. But other than that, he’s fine.”

The Red Sox will presumably ease Sale into things once he is healthy enough to fully report to camp.

The Florida native is entering the first year of the five-year, $145 million extension he signed with Boston last spring.

Red Sox’ Chris Sale Receives PRP Injection, Will Be Re-Evaluated in Six Weeks

After it was revealed that left-hander Chris Sale would not need Tommy John Surgery, the Red Sox announced that the 30-year-old received a platelet-rich plasma injection during his visit with Dr. James Andrews on Monday.

Dr. Andrews confirmed that Sale did indeed have inflammation in his throwing elbow prior to the injection, and recommended a shutdown period of six weeks before being re-evaluated once more.

Here’s the official statement from Red Sox president of baseball operations Dave Dombrowski.

As you may have already figured out, six weeks from now is September 30th, meaning that Sale’s 2019 season is likely over. Dombrowski confirmed that himself, per MLB.com’s Ian Browne.

If that is indeed the case, the Florida native’s third year with Boston was rather underwhelming.

In 25 starts, Sale posted a 4.40 ERA and .221 batting average against over 147 1/3 innings pitched, presumably ending his run of seven straight seasons finishing in the top seven for American League Cy Young Award voting. The Red Sox went 10-15 in those games.

As mentioned earlier, Sale will be re-evaluated by Dr. Andrews in late September. For now, the Red Sox need to find someone to take their ace’s spot in the starting rotation.

Red Sox’ Chris Sale Does Not Need Tommy John Surgery, per Report

Red Sox left-hander Chris Sale does NOT need to undergo Tommy John surgery, according to ESPN’s Jeff Passan.

Sale, 30, was placed on the 10-day injured list this past Saturday due to left elbow inflammation. The move was retroactive to August 14th.

Along with Sox head athletic trainer Brad Pearson, Sale traveled to Pensacola, Fla. on Monday to receive a second opinion on his elbow from Dr. James Andrews after undergoing an MRI on Saturday.

When Dr. Andrews’ name is brought up in these scenarios, bad news usually ensues, but this time around, the knee, elbow, and shoulder specialist confirmed the initial diagnosis of inflammation in Sale’s throwing elbow.

Through 25 starts this season, Sale has posted an ERA of 4.40 and batting average against of .221 to go along with 218 strikeouts over 147 1/3 innings pitched. That includes an outing in which he punched out 12 to surpass the 2,000 mark for his career in his last time out before hitting the IL against the Cleveland Indians on Tuesday.

According to MassLive.com’s Christopher Smith, an official statement from the Red Sox pertaining to Monday’s events will be released shortly, so stay tuned for that.